In this episode, Dr. Angela Tran, an obesity medicine specialist, discusses the challenges faced by postmenopausal and perimenopausal women regarding weight management and hormonal changes. The conversation covers the role of GLP-1 medications, the impact of insulin resistance, and the importance of self-care and boundaries. Dr. Tran emphasizes the need for a holistic approach to health, including nutrition, exercise, and mental well-being, while also addressing the future of obesity medicine and the evolving landscape of weight management treatments.
About Dr. Angela Tran:
Founder of Med-Fit Medical Weight Loss since 2012. She helps females in their 40s/50s frustrated with yo-yo dieting, struggling with hormones, thyroid problems, belly fat, and other metabolic conditions, and finally break free by incorporating medical lab work, a team of health coaches, and Board Certified Obesity Medicine expert guidance to create predictable weight loss and sustainability.
Website: https://www.medfitmedicalweightloss.com
Instagram: https://www.instagram.com/medfitdrtran
Thank you to our sponsors:
Visit resbiotic.com and use the code GLP1HUB20 to get 20% off your order
Visit Hero.co and use the code GLP1HUB for 10% off
Visit Gruns.co and use the code GLP1HUBPOD to get up to 52% off your order
Visit our GLP-1 Hub store:
Get our FREE 7-day meal plans for GLP-1:
Want to connect more with GLP-1 Hub?
Instagram: https://www.instagram.com/glp1hub
Tiktok: https://www.tiktok.com/@glp1hub
YouTube: https://www.youtube.com/@glp-1hub
Weekly newsletter with weight loss tips and podcast updates: https://glp1hub.myflodesk.com/rn9j3lxjpp
*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.
*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.
